Showing 1-10 out of 118
Page 1 of 1212345...10...»Last »
Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled, Phase 3 KONFIDENT TrialReidl MA, Aygören-Pürsün E, Lumry WR, Farkas H, Zanichelli A, Hao J, Iverson M, Smith MD, Yea CM, Audhya PK, Bernstein JA, Maurer M, Cohn DM
CIIC 2024
Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary AngioedemaFeener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM
Drugs and Drug Candidates
Relationship Between Time to On-demand Treatment and Quality of Life During Hereditary Angioedema AttacksChristiansen S, Craig T, O’Connor M, Radojicic C, Ulloa J, Danese S, Desai V, Andriotti T, Audhya P, Busse P
2024 HAEi Regional Conference
Delayed On-Demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated BarriersChristiansen S, O’Connor M, Ulloa J, Danese S, Desai V, Audhya P, Busse P
2024 HAEi Regional Conference
Characterizing the Negative Impact of Delayed On-Demand Treatment of HAE AttacksOgbogu P, Longhurst H, van Kooten S, Malloy N, Heckmann M, Ulloa J, Zwiener R
2024 HAEi Regional Conference
Anxiety Associated with Refilling On-demand Therapy for HAE Attacks Contributes to Treatment Delay and Non-TreatmentSoteres DF, Grumach AS, van Kooten S, Malloy N, Heckmann M, Ulloa J, Burnette A
2024 HAEi Regional Conference
Characteristics of Hereditary Angioedema Attacks Among Long-Term Prophylaxis UsersGeng B, Desai V, Ulloa J, Danese S, Audhya P, Craig T
2024 HAEi Regional Conference
Treatment Patterns of Patients Requiring Redosing of an On-demand Treatment After the Return of an HAE AttackKatelaris C, Manning M, van Kooten S, Malloy N, Heckmann M, Ulloa J, Lumry W
2024 HAEi Regional Conference
Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) AttacksWedner J, Radojicic C, Ulloa J, Danese S, Desai V, Audhya P, Christiansen S
2024 HAEi Regional Conference
POSTER & SUPPLEMENT: Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled Phase 3 KONFIDENT TrialMarc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Henriette Farkas, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn
AAAAI 2024